Global Health Clinics Ltd.
CA$0.40CA$0.00 (0.0%)
Global Health Clinics Ltd.’s quoted price sits in the upper half of its reported 52-week range, 9.09% below the high.
CNQ · OMND.CN · CAD
Stock price, earnings
Quote as of Aug 19, 2025, 05:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Optimind Pharma Corp.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Optimind Pharma Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Optimind Pharma Corp. is a Canadian pharmaceutical enterprise headquartered in Toronto. The company specializes in offering psychedelic-based therapies, including ketamine-assisted treatment and other advanced psychedelic-enhanced psychotherapy modalities, targeting mental health conditions such as post-traumatic stress syndrome, anxiety, depression, and various other psychological disabilities. Additionally, Optimind Pharma operates a dedicated clinic that provides patients with medical cannabis and a range of alternative medical treatments, notably featuring ketamine-enhanced psychotherapy as part of its offerings.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:49 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.40CA$0.00 (0.0%)
Global Health Clinics Ltd.’s quoted price sits in the upper half of its reported 52-week range, 9.09% below the high.
CA$0.01+CA$0.01 (+100.0%)
RAMM Pharma Corp.’s quoted price sits in the lower half of its reported 52-week range, 96.0% below the high.
CA$0.22-CA$0.01 (-4.35%)
Captor Capital Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.28% below the high.
CA$0.63CA$0.00 (0.0%)
Vibe Growth Corporation’s quoted price sits in the upper half of its reported 52-week range, 21.25% below the high.
CA$0.10-CA$0.03 (-23.08%)
Vaxil Bio Ltd.’s quoted price sits in the lower half of its reported 52-week range, 65.52% below the high.
CA$0.01CA$0.00 (0.0%)
Greenrise Global Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.02$0.00 (0.0%)
TripSitter Clinic Ltd.’s quoted price sits in the lower half of its reported 52-week range, 78.27% below the high.
$0.01$0.00 (0.0%)
CENTR Brands Corp.’s quoted price sits in the lower half of its reported 52-week range, 83.38% below the high.